Latest Commercial Modelling News

Gold Hydrogen is accelerating Helium development at its Ramsay Project, leveraging exceptional purity results and independent modelling amid a tightening global Helium supply.

Xenitra Limited's OPAL Real World Asset tokenised sales ecosystem has generated over $500,000 in sales within its first month, onboarding more than 130 distributors and positioning the company as an early mover in blockchain-enabled FMCG sales in China.

dorsaVi has initiated its Ultra-Edge Modular Design program, transitioning from IP development to a manufacturable hardware platform targeting robotics, exoskeletons, and industrial AI with ultra-low power consumption.

Entropy Neurodynamics has unveiled a striking 75% response rate in a small Phase 2a trial of its oral psilocybin therapy for treatment-resistant irritable bowel syndrome, far surpassing existing treatments and validating its gut-brain axis approach.

EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.

InteliCare has inked a $200,000 contract to deploy its AI-powered monitoring platform across 65 retirement villas at Warrigal's new development, marking its first foray into the retirement living sector with potential for wider rollout.

Mount Hope Mining (ASX:MHM) has completed Phases 1 and 2 drilling at its Mt Solitary gold project in NSW’s Cobar Basin, delivering high-grade intercepts including visible gold up to 52.5 g/t and defining an exploration target of 1.3-1.9 million tonnes at 1.0-1.35 g/t Au.

Audeara has locked in exclusive Australian rights to a customised assistive listening device from ShokzHear, aiming to tackle widespread listening challenges among schoolchildren through government-backed programs.

Metallium Limited has marked a pivotal quarter with over 40 Flash Joule Heating campaigns completed and a strategic capital raise boosting cash reserves to A$82 million. The company is gearing up for multi-reactor operation at its Texas campus, underpinned by long-term agreements with Indium Corporation and Glencore.

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

Adherium Limited reports a strong uptick in Remote Patient Monitoring revenue and device activations, driven by new reimbursement codes and strategic partnerships, aiming for 10,000 RPM patients by year-end.

AI-Media Technologies has reported a robust first half of FY26, achieving an 80% increase in annual recurring revenue driven by its LEXI suite and unveiling a new Hardware as a Service model set to transform its business.